Looking to the East

The Chicago Mercantile Exchange (CME) has been busy in China educating local government officials and regulators on the use of derivatives. Jill Wong talks to CME chief executive Craig Donohue and chairman emeritus Leo Melamed about the exchange's push into China

pg55-craig-donohue-gif

Cooperation between Western and Asian exchanges has been on the rise in recent years. Euronext is due to open an Asian telecommunications hub in Singapore, following a similar move by the Chicago Mercantile Exchange (CME) in June this year. In August, the Chicago Board of Trade (CBOT) signed a memorandum of understanding (MOU) with the Singapore Exchange for the development of a commodity derivatives exchange, which is expected to start operating in the first half of 2006.

In China, the CME is

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here